JPY 4241.0
(1.19%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 117.61 Billion JPY | 15.62% |
2022 | 101.72 Billion JPY | 9.68% |
2021 | 92.75 Billion JPY | 14.85% |
2020 | 80.75 Billion JPY | 10.16% |
2019 | 73.3 Billion JPY | 41.51% |
2018 | 51.8 Billion JPY | 3.63% |
2017 | 49.99 Billion JPY | -4.11% |
2016 | 52.13 Billion JPY | -0.4% |
2015 | 52.34 Billion JPY | 3.22% |
2014 | 50.71 Billion JPY | 16.8% |
2013 | 43.42 Billion JPY | 22.1% |
2012 | 35.56 Billion JPY | 16.34% |
2011 | 30.56 Billion JPY | 38.6% |
2010 | 22.05 Billion JPY | -1.24% |
2009 | 22.33 Billion JPY | 12.75% |
2008 | 19.8 Billion JPY | 0.8% |
2007 | 19.65 Billion JPY | 15.1% |
2006 | 17.07 Billion JPY | 3.67% |
2005 | 16.46 Billion JPY | 5.19% |
2004 | 15.65 Billion JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 126.91 Billion JPY | 7.9% |
2023 Q4 | 117.61 Billion JPY | 5.11% |
2023 FY | 117.61 Billion JPY | 15.62% |
2023 Q3 | 111.89 Billion JPY | -0.47% |
2023 Q2 | 112.43 Billion JPY | 4.59% |
2023 Q1 | 107.5 Billion JPY | 5.68% |
2022 FY | 101.72 Billion JPY | 9.68% |
2022 Q1 | 95.9 Billion JPY | 3.4% |
2022 Q3 | 101.07 Billion JPY | 0.31% |
2022 Q2 | 100.76 Billion JPY | 5.07% |
2022 Q4 | 101.72 Billion JPY | 0.64% |
2021 Q2 | 87.1 Billion JPY | 3.12% |
2021 FY | 92.75 Billion JPY | 14.85% |
2021 Q4 | 92.75 Billion JPY | 6.34% |
2021 Q1 | 84.47 Billion JPY | 4.6% |
2021 Q3 | 87.21 Billion JPY | 0.13% |
2020 Q3 | 75.39 Billion JPY | 3.3% |
2020 Q2 | 72.98 Billion JPY | -2.89% |
2020 FY | 80.75 Billion JPY | 10.16% |
2020 Q1 | 75.16 Billion JPY | 2.53% |
2020 Q4 | 80.75 Billion JPY | 7.11% |
2019 Q3 | 56.48 Billion JPY | -0.42% |
2019 FY | 73.3 Billion JPY | 41.51% |
2019 Q1 | 55.11 Billion JPY | 6.38% |
2019 Q4 | 73.3 Billion JPY | 29.78% |
2019 Q2 | 56.72 Billion JPY | 2.93% |
2018 FY | 51.8 Billion JPY | 3.63% |
2018 Q4 | 51.8 Billion JPY | 2.92% |
2018 Q3 | 50.33 Billion JPY | -0.74% |
2018 Q2 | 50.71 Billion JPY | 2.01% |
2018 Q1 | 49.71 Billion JPY | -0.57% |
2017 FY | 49.99 Billion JPY | -4.11% |
2017 Q1 | 50.31 Billion JPY | -3.5% |
2017 Q2 | 48.88 Billion JPY | -2.83% |
2017 Q4 | 49.99 Billion JPY | 0.51% |
2017 Q3 | 49.73 Billion JPY | 1.74% |
2016 Q1 | 51.9 Billion JPY | -0.85% |
2016 FY | 52.13 Billion JPY | -0.4% |
2016 Q3 | 50.27 Billion JPY | 1.4% |
2016 Q4 | 52.13 Billion JPY | 3.69% |
2016 Q2 | 49.58 Billion JPY | -4.47% |
2015 Q2 | 50.3 Billion JPY | -1.65% |
2015 FY | 52.34 Billion JPY | 3.22% |
2015 Q1 | 51.15 Billion JPY | 0.86% |
2015 Q3 | 51.67 Billion JPY | 2.71% |
2015 Q4 | 52.34 Billion JPY | 1.31% |
2014 FY | 50.71 Billion JPY | 16.8% |
2014 Q4 | 50.71 Billion JPY | 1.24% |
2014 Q3 | 50.09 Billion JPY | 1.4% |
2014 Q2 | 49.4 Billion JPY | 2.62% |
2014 Q1 | 48.14 Billion JPY | 10.87% |
2013 Q3 | 42.64 Billion JPY | 4.99% |
2013 Q4 | 43.42 Billion JPY | 1.82% |
2013 FY | 43.42 Billion JPY | 22.1% |
2013 Q2 | 40.61 Billion JPY | 6.9% |
2013 Q1 | 37.99 Billion JPY | 6.84% |
2012 Q3 | 34.06 Billion JPY | -1.08% |
2012 Q4 | 35.56 Billion JPY | 4.39% |
2012 Q1 | 32.84 Billion JPY | 7.45% |
2012 Q2 | 34.44 Billion JPY | 4.86% |
2012 FY | 35.56 Billion JPY | 16.34% |
2011 Q3 | 27.94 Billion JPY | 4.96% |
2011 FY | 30.56 Billion JPY | 38.6% |
2011 Q1 | 24.2 Billion JPY | 9.73% |
2011 Q2 | 26.62 Billion JPY | 9.99% |
2011 Q4 | 30.56 Billion JPY | 9.41% |
2010 Q2 | 22.55 Billion JPY | -0.8% |
2010 Q1 | 22.73 Billion JPY | 1.8% |
2010 FY | 22.05 Billion JPY | -1.24% |
2010 Q4 | 22.05 Billion JPY | -5.76% |
2010 Q3 | 23.4 Billion JPY | 3.77% |
2009 Q4 | 22.33 Billion JPY | 2.35% |
2009 Q2 | 21.29 Billion JPY | 0.0% |
2009 Q3 | 21.82 Billion JPY | 2.47% |
2009 FY | 22.33 Billion JPY | 12.75% |
2008 Q3 | 20.22 Billion JPY | 0.0% |
2008 FY | 19.8 Billion JPY | 0.8% |
2008 Q4 | 19.8 Billion JPY | -2.06% |
2007 FY | 19.65 Billion JPY | 15.1% |
2006 FY | 17.07 Billion JPY | 3.67% |
2005 FY | 16.46 Billion JPY | 5.19% |
2004 FY | 15.65 Billion JPY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -1651.02% |
Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 90.279% |
Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | -1.964% |
Shionogi & Co., Ltd. | 64.91 Billion JPY | -81.182% |
Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -5763.108% |
Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | -200.724% |
Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | -585.128% |
Eisai Co., Ltd. | 174.65 Billion JPY | 32.657% |
Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -3592.81% |
Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | -455.421% |
Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | -288.454% |
Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | -728.165% |
Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | -996.96% |
Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | -347.277% |
Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | -994.917% |
Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | -16.369% |
Fuji Pharma Co., Ltd. | 19.37 Billion JPY | -507.176% |
Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | -711.718% |
KYORIN Holdings, Inc. | 53.47 Billion JPY | -119.966% |
Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -5925.41% |
Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | -463.025% |
SymBio Pharmaceuticals Limited | 232.03 Million JPY | -50589.997% |
MedRx Co., Ltd | 10 Million JPY | -1176060.0% |
Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -7266.617% |
Solasia Pharma K.K. | 122 Million JPY | -96306.557% |
Modalis Therapeutics Corporation | 6.35 Million JPY | -1851245.821% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | -476.493% |
Sawai Group Holdings Co., Ltd. | 100 Billion JPY | -17.614% |
Cyfuse Biomedical K.K. | 46.04 Million JPY | -255337.072% |
Toho Holdings Co., Ltd. | 87.28 Billion JPY | -34.746% |
Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -5089.877% |